Symetis gains access to US market

Switzerland-based Symetis GmbH has made a major step onto the US medical device market after agreeing to be acquired by Boston Scientific Corp. The deal, announced on 30 March, consolidates the two companies’ technologies for treating valvular heart disease.

Full text available to subscribers only. Click here for information on subscribing to MedNous.